REGULATORY COMPLIANCE – Page 51

Electronic Records Decommissioning: Archive and Retrieval Strategy

Identifying failure signals is crucial for timely interventions. Common symptoms associated with ineffective electronic records decommissioning include:Click to read the full article.

ERES Compliance for Analytical Instrument Data Systems

Identifying the symptoms of potential non-compliance in analytical instrument data systems is the first critical step. Here are common indicators that may suggest a lapse in compliance:Click to read the…

How to Monitor ERES Controls Using Quality Metrics

Recognizing symptoms of potential issues in electronic records management is the first step toward ensuring compliance. Common signals may include:Click to read the full article.

Electronic Records Inspection Questions and Best Responses

In a mid-sized pharmaceutical manufacturing facility, the Quality Control (QC) department noticed several discrepancies in the electronic records generated during batch release testing. Some laboratory documents appeared incomplete, and electronic…

ERES Roadmap for Moving from Paper to Digital GMP Systems

Recognizing early signs of failure in transitioning from paper to digital GMP systems is crucial to ensuring compliance and operational stability. Below are common symptoms that may arise:Click to read…

Good Documentation Practices in Pharma: Practical GDP and ALCOA+ Guide

Documentation errors can manifest in various ways across pharmaceutical manufacturing and quality control environments. By recognizing these symptoms early, professionals can take timely corrective actions. Common signals include:Click to read…

How to Apply ALCOA+ Principles in Daily GMP Documentation

Identifying symptoms or signals of poor documentation practices is the first step in addressing compliance issues. Common signs include:Click to read the full article.

GDP Errors in Batch Records and How to Prevent Them

GDP errors may manifest in various ways during manufacturing and quality control processes. As a first step, it is vital to recognize the symptoms that indicate a potential failure in…

Good Documentation Practices for QA, QC, and Manufacturing Teams

In the presented scenario, the Quality Control (QC) team identified inconsistencies during the batch record review process. Symptoms included:Click to read the full article.

How to Write Contemporaneous GMP Records Without Data Integrity Gaps

Common signals on the manufacturing floor or in the laboratory indicating potential data integrity issues include:Click to read the full article.

GDP Corrections: What Is Acceptable and What Inspectors Challenge

Indicators of documentation deficiencies can manifest in various ways throughout the pharmaceutical manufacturing process. Common symptoms include:Click to read the full article.

ALCOA+ Explained for Pharma Shop Floor and Laboratory Teams

Understanding ALCOA+ for Enhanced Documentation on the Pharma Shop Floor The principles of ALCOA+ have become fundamental in ensuring data integrity in pharmaceutical manufacturing environments. However, many professionals still struggle…